NextCure, Inc. — Form 8-K
Filed November 20, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 8/100
What the filing says
The 8-K filing dated 2026-11-20 contains Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits), but the actual disclosure text is not provided in the metadata extract. The filing includes XBRL data files but no specific business event, transaction, or financial detail is visible from this submission wrapper.
Why this rating
Cannot assess significance without actual filing content. 8-K itself signals disclosure event, but no dollar amounts, counterparties, or business impact are stated in the metadata provided.
Extracted items
- 7.01 Reg FD disclosure
- 9.01 exhibits
See more from November 20, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.